Mulder, M.B. et al. 2021. Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). Acta Oncologica. 60, 4 (Apr. 2021), 539–543. DOI:https://doi.org/10.1080/0284186X.2020.1862908.